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Abstract
The envelope of HSV-1 contains a number of glycoproteins, four of which are essential for virus entry. Virus particles lacking gB,
gD, gH or gL are entry-defective, although these viruses retain the ability to bind to the plasma membrane via the remaining
glycoproteins. Soluble forms of gD have been shown to trigger the nuclear translocation of the NF-kB transcriptional complex in
addition to stimulating the production of Type I interferon. By taking advantage of the entry-defective phenotype of
glycoprotein-deficient HSV-1 virus particles, the results presented here show that binding of virions to cellular receptors on the
plasma membrane is sufficient to stimulate a change in cellular gene expression. Preliminary microarray studies, validated by
quantitative real-time PCR, identified the differential expression of cellular genes associated with the NF-kB, PI3K/Akt, Jak/Stat
and related Jak/Src pathways by virions lacking gB or gH but not gD. Gene induction occurred at a few particles per cell,
corresponding to physiological conditions during primary infection. Reporter assay studies determined that NF-kB transcriptional
activity is stimulated within an hour of HSV-1 binding, peaks between two and three hours post-binding and declines to
background levels by five hours after induction. The immediate, transient nature of these signalling events suggests that HSV-1
glycoproteins, particularly gD, may alter the cellular environment pre-entry so as to condition the cell for viral replication.
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Introduction
Subjugation of the intracellular environment by viruses is
essential to ensure the effective expression and replication of the
viral genome to allow production of progeny virions. One such
viral strategy involves hijacking signalling pathways that ultimately
control host gene transcription. Interactions between intracellular
viral proteins and cellular kinases responsible for signal transduc-
tion are a means by which to achieve this. However, there is
growing evidence to support the premise that glycoproteins on the
surface of virus particles may trigger intracellular signalling
pathways by interacting with their cognate receptors on the host
cell membrane [1].
Binding of HSV-1 to permissive cells occurs through viral
glycoproteins on the viral envelope interacting with specific
receptors on the cell surface, triggering fusion of the plasma
membrane with the outer envelope. Five of these glycoproteins
are known to be involved in virion binding to the cell surface: gB,
gC, gD and the heterodimer gH-L. Of the five, only gC is
dispensable for allowing productive infection as deletion of gB,
gD or gH-L results in an entry-defective phenotype [2][3]. gD is
known to bind independently to HvEM, nectin-1 and nectin-2,
whereas gH interacts with the avb3 integrin, with the paired
immunoglobulin-like receptor, PILRa, acting as a receptor for gB
[2][4][5].
One of the first studies to examine whether HSV-1 glycopro-
teins play a role in the induction of signalling found that gD was
able to block Fas-mediated apoptosis [6]. U937 monocytoid cells
were rendered resistant to apoptosis after infection with UV-
inactivated HSV virions, when co-cultured with a stably trans-
fected HSV-1 gD-expressing cell line or after treatment with
soluble gD. Inhibition of NF-KB signalling by the introduction of
a dominant-negative NF-kB repressor abolished protection from
gD-induced Fas-mediated apoptosis. More specifically, the
interaction of gD with one of the gD receptors, HVEM, was
involved in preventing apoptosis induction [1].
There are reports showing that HSV-1 triggered the translocation
of NF-kB by six hours post-infection [7]. However, it has come to
light that HSV-1 may induce two distinct phases of NF-kB activity.
The initial phase is transient, lasting only two hours, and occurred
shortly after viral adsorption by both wild-type and UV-inactivated
virus particles. This correlates with evidence showing that
supernatant taken from gD-expressing cells may also cause an
increase in NF-KB binding activity in monocytoid cells by 30
minutes post-treatment [6]. A second phase relied on de novo viral
protein synthesis as it was stimulated only by replication-competent
HSV-1 and not by UV-inactivated virions [8]. During this second
phase, NF-kB complexes were shown to have associated with their
consensus sequence found in the promoter region that drives ICP0
expression [8].
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unable to bind to HVEM did not stimulate NF-KB activity in co-
cultured monocytoid cells [9]. HEp-2 cells, which do not express
HVEM, lacked detectable NF-kB signalling after infection with
UV-inactivated HSV-1, implying that gD-mediated NF-kB
stimulation may be dependent on expression of HVEM [9].
Soluble glycoproteins from beta- and gammaherpesviruses can
also stimulate intracellular signalling pathways; gB of CMV has
been shown to stimulate the differential expression of cellular
transcription factors and interferon-stimulated genes (ISGs), and
soluble gp350 of EBV can trigger NF-kB activation [10] [11][12].
The treatment of cells with soluble glycoproteins or UV-
inactivated virus has provided strong evidence that HSV-1 binding
to the plasma membrane triggers signal transduction in the host
cell as a prelude to infection, but interpretation of these
experiments is not straightforward. The use of soluble glycopro-
teins does not mimic the binding of individual virus particles and
the physiological significance of the results is difficult to assess. The
use of UV-inactivated particles in signalling studies simulates
infection but these particles are able to enter cells and deliver
virion proteins to the cytoplasm. Experiments with UV-inactivated
particles do not therefore distinguish between events arising from
virus binding from those resulting from virus entry.
The main focus in these studies was to examine signalling events
using virus particles that are capable of binding to the cell surface
but are incapable of entry due to the absence of one of the three
essential glycoproteins, gB, gD or gH [13][14][15][16], and to find
whether signalling occurs at particle concentrations that would
mirror physiological conditions.
Materials and Methods
Viruses and Cells
All cells other than Human Foreskin Fibroblasts (HFF) (ATCC
cell line CRL-2522) were grown in Glasgow Modified Eagles
Medium supplemented with 10% foetal bovine serum, 4 mM
glutamine, 100 units/ml penicillin and 100 ug/ml streptomycin.
HFF cells were grown in Dulbecco modified Eagles medium
supplemented as described above but with the addition of 1x
MEM non-essential amino acids.
Working stocks of HSV-1 SC16 were grown on HaCaT cells
and assayed on Vero cells [17]. Mutant viruses lacking functional
genes for gH (SCgHZ) [14], gB (HFEMdUL27-lacZ) [18] or gD
(SC16gDdelZ) [18] were grown and assayed on helper cell lines
expressing the corresponding glycoprotein: CR1 cells, expressing
gH [19]; D6 cells expressing gB [13]; and VD60 cells expressing
gD [18]. All stocks were grown using an MOI of 0.1.
Purified preparations of WT virus, or of virions lacking
individual glycoproteins, were produced as previously described
[20]. Purified preparations were assayed for particle numbers
using electron microscopy [21] and for infectivity by plaque assay
on Vero cells or, in the case of glycoprotein-deficient virions, on
the relevant helper cell line. Preparations of WT virions had
a particle to infectivity ratio of 3610
1. Preparations of gH-
negative, gD-negative and gB negative virions had particle to
infectivity ratios of 2610
10,5 610
6 and 3610
6 respectively. The
maximum virion dose of entry-incompetent virions used in the
experiments described in this paper was 1000 particles per cell and
it therefore follows that in the maximum infectivity of a preparation
of an entry-defective virus (i.e. using gB-negative virions) would be
less than one cell per thousand. Virus preparations were
deglycosylated with 500 U of PNGase F for 18 hrs at 37uCi n
the absence of denaturing buffer [22]. Removal of N-linked sugars
was confirmed by a shift in the electrophoretic mobility of gD on
a protein denaturing gel.
Signalling Experiments
Human foreskin fibroblast cells (HFF) were seeded at 1.5610
6
in a 175
2 cm flask and grown to 90% confluence then growth-
arrested in medium supplemented with only 100 U/ml Penicillin-
G and 100 mg/ml Streptomycin for five days. Real-time PCR
experiments were conducted with growth-arrested HFFs that were
inoculated in triplicate with 1000 particles/cell of entry-defective
HSV-1 in warm, serum-free medium, with parallel mock-infected
cells that received an equivalent volume of PBS in warm serum-
free medium. Inoculations took place at 37uC. At the indicated
times after the addition of virus, the medium was removed, the
cells were lysed with TRI Reagent (Sigma) and total RNA was
immediately purified. For each entry-defective HSV-1 mutant,
three independent biological replicates were carried out. Micro-
array experiments were conducted under the same conditions
using wild-type HSV-1 (SC16) at an MOI of 20.
RNA Purification and cDNA Preparation
Total RNA was isolated from TRI reagent lysates as per the
manufacturer’s instructions. Contaminating genomic DNA was
digested with 2 U DNase I (Invitrogen) and RNA was re-purified
with TRI reagent. cDNA was derived from 30 mg total RNA using
anchored oligo (dT)20 primers (Invitrogen) as described in the
manufacturer’s instructions. For each entry-defective HSV-1
mutant, the cDNA from three independent infections were used
in technical triplicates for real-time PCR reactions.
Signalling-Specific Microarray
Microarray analysis was carried out using the Signal Trans-
duction PathwayFinder cDNA array as per the manufacturer’s
instructions (Superarray). Nylon cDNA microarrays membranes
were pre-hybridised with supplied sheared salmon sperm DNA at
60uC for one to two hours. The pre-hybridisation solution was
replaced with the biotin-dUTP labelled cDNA probe, which was
diluted in sheared salmon sperm DNA. The solution was left to
hybridise at 60uC overnight. The following morning the cDNA
probe was discarded and the membrane was washed twice then
blocked in Solution Q, as provided by the manufacturer. After 40
minutes, the blocking solution was discarded and the membrane
was incubated with a binding buffer, Solution F. After washing,
the chemiluminescent substrate was incubated with the membrane
for two to five minutes at room temperature. The microarray
membrane was then exposed to X-ray film. Analysis was
performed using GEArray Expression Analysis Suite as provided
by the manufacturer (Superarray). All the data sets used in the
microarray analysis are available in Table S1.
Real-Time PCR
cDNA derived from cells that were mock-infected or inoculated
with 1000 particles/cell of entry-defective DgB, DgD and DgH
virions was used for real-time PCR analysis. Primers were
designed, using the Primer3 software [23], to anneal at 60uC,
with a minimum product melting temperature of 80uC (Table S2).
Reactions were set-up with cDNA corresponding to 100 ng total
RNA, primers (70 nM), and 10 ml SYBR Green PCR master mix
(Abgene) made to a total volume of 20 ml with nuclease-free
dH2O. A Corbett Rotorgene 3000 was used to determine the
levels of SYBR green fluorescence over 40 cycles. Samples were
denatured for 10 minutes at 95uC, annealed at 60uC for 30
seconds, with extension of the primer product at 72uC for 40
Signaling by HSV Glycoproteins
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background fluorescence from primer-dimers. A melt curve
analysis was produced at the end of the cycling to ensure the
specificity of PCR product amplification and associated SYBR
green fluorescence. Relative gene expression levels between mock-
inoculated and inoculated cells were calculated using the Pfaffl
method with potential variations in cDNA quantity between
samples normalised to the transcript for ribosomal protein L13a
(RPL13a) [24]. Serial dilutions of PCR product across 8 logs were
used to determine the efficiency of PCR amplification for each
primer set under the above conditions so that the relative
quantitation could be adjusted as defined by the Pfaffl method.
A relative change in expression of two-fold was set as a threshold
for determining whether differential expression of a gene had
occurred. The p values associated with the fold-change in
expression were calculated using a Students t-test on the real-
time PCR CT values comparing triplicate mock-inoculated and
HSV inoculated cells.
Luciferase Assays
An NF-kB reporter assay system was designed using a pGL4-
NFkB construct (Promega). Quadruplicate repeats of the NF-kB
binding consensus sequence 59-GGGAATTTCC-39 were excised
from a p-NF-kB-Luc (Gift from Dr. Heike Laman, University of
Cambridge) vector using KpnI and HindIII and ligated into the
pGL4.20 vector multiple cloning site using the same restriction sites.
pGL4.20 was chosen as it is optimized for more efficient expression in
mammalian cells, compared to previous generations of luciferase
constructs, and contains fewer transcription factor consensus
sequences such that background luciferase expression is reduced.
HFFs were electroporated in batches of 6610
5 cells per cuvet
(Amaxa) with 2 mgo fp G L 4 - N F - kB, pooled together and aliquoted at
10
5 cells per well of a 24-well plate. After 48-hours recovery in
supplemented media, the transfected HFFs were serum-starved for
five days. HFFs were inoculated with 1000 particles/cell of DgH
HSV-1 and were lysed at the indicated time points in 100 ml passive
lysis buffer (Promega) and 20 mlo fl y s a t ew e r ee x a m i n e df o rl u c i f e r a s e
activity using 50 ml assay buffer (Promega).
Western Blotting
gD and the major tegument protein, VP16, were detected by
immunoblotting using the monoclonal antibodies LP2 and LP1,
respectively [25–26]. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting were performed
as described previously [27].
Results
Differential Cellular Gene Expression at Early Time-Points
after Wild-Type HSV-1 Infection
Signalling-specific microarrays were chosen as an initial route to
identifying signalling pathways that may be stimulated early in
HSV-1 infection, and more precisely, by virion binding. The
Signal Transduction PathwayFinder cDNA array from Superarray
incorporates 96 targets covering 19 associated signalling pathways,
in addition to two negative controls corresponding to pUC18
plasmid DNA and a ‘blank’ spot, as well as four positive controls
representing the housekeeping genes for GAPDH, beta actin,
cyclophilin A and ribosomal protein L13a.
Serum-starved HFFs were inoculated with 1000 particles/cell of
DgB, DgD or DgH entry-defective HSV-1 virions. Total RNA was
isolated immediately after inoculation, corresponding to 0 hpi,
and 6 hpi. Changes in gene expression associated with the
activation of signalling pathways were identified by comparison
to the transcript abundance at 0 hpi. The results from duplicate
experiments indicated that downstream gene targets of a number
of signalling pathways are differentially expressed above the two-
fold threshold after virion binding (Table 1). These preliminary
results were then used as the basis of quantitative PCR studies.
Using the same methodology, serum-starved HFF cells were
exposed to 1000 particles per cell of virions lacking either gD, gB
or gH and RNA was extracted for cDNA synthesis immediately
(0 h) or after 6 h. Table 2 gives the results of three independent
experiments for those genes that were differentially expressed
between 0 h and 6 h post treatment and is compared to the initial
microarray results in Table 3. It is striking that in virtually every
instance where gene expression is modified by virion binding, gD
appears to be the key effector. Virions lacking gH or gB had were
capable of altering cellular gene expression while those lacking gD
had no significant effect. The results can be summarised as follows.
JAK/STAT and JAK/Src Pathways
The JAK/STAT and related JAK/Src pathway show a similar
response to that seen for NF-kB. Of the JAK/STAT-responsive
genes, only NOS2A is regulated by more than one pathway, with
DgB and DgH virions inducing their transcription and DgD
particles having no significant effect (Table 2). Although the JAK/
Src pathway has only two targets on the signalling microarrays -
upon which the real-time PCR experiments were based - BCL2L1
is unique to the pathway, with BCL2 expression regulated by
multiple signalling routes. Interestingly, while DgB and DgH
virions up-regulated BCL2 and BCL2L1, DgD virus particles
appeared to down-regulate both targets by a significant amount.
PI3K/Akt Pathway
Induction of this pathway may be responsible for the upregulation
of CCND1, MYC, BCL2 and MMP7 after inoculation with DgB
and DgH but not DgD HSV-1 (Table 2). Differential expression of
CCND1 and MYC can be regulated by the Wnt and PI3K
signalling pathways, with MYC also being controlled by Protein
Kinase C. The up-regulation of MMP7, which is the only target
unique to the PI3K pathway that is differentially expressed,
highlights the potential crosstalk between signalling pathways and
cannot exclude the involvement of PI3 kinase signalling as a pathway
leading to transcription of all four cellular genes.
NF-kB Pathway
Both DgB and DgH virions are capable of stimulating an NF-kB
response (Table 2), a result that correlates with the preliminary
microarray data (Table 1). Transcripts for both BIRC-2 and
BIRC-3 are increased above the two-fold threshold after
inoculation with DgB and DgH HSV-1 but not DgD. There
appears to be no change in BIRC-1 expression after inoculation
with any of the three entry-defective mutants. Components of the
NF-kB transcriptional complex, NFKB1 and REL, showed similar
levels of increased transcription after binding by DgB and DgH
virions, a response that was absent in cells stimulated with gD-
deficient virions. Two markers of inflammation, CCL2 and
PECAM1, also showed a significant change in gene expression
at 6 hpi with entry-defective HSV-1 lacking gB or gH but not gD.
The downstream signalling appears specific as not all NF-kB
targets were up-regulated. The NF-kB repressors, NFKBIA and
NFKBIB, were only up-regulated by DgB virion binding (Table 2).
Kinetics of NF-kB Activation
To confirm that virion binding induces NF-kB and to examine
the kinetics, an NF-kB promoter-driven luciferase construct was
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Gene Description DgB DgD DgH
NF-KB
BCL2A1 hematopoietic BCL2-related protein A1 23.85 * 5.56 1.42
BIRC1 baculoviral IAP repeat-containing 1 22.33 21.12 23.13 **
BIRC2 baculoviral IAP repeat-containing 2 3.85 3.98 1.72
BIRC3 baculoviral IAP repeat-containing 3 2.88 1.00 7.71 ***
CCL2 macrophage chemoattractant protein-1 2.32 * 1.34 2.13 *
LTA lymphotoxin alpha (TNF superfamily, member 1) 21.22 2.31 21.20
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) 2.98 * 21.92 3.09 **
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 21.19 1.23 2.54 **
PECAM1 platelet/endothelial cell adhesion molecule (CD31 antigen) 4.60 * 1.00 3.09 *
JAK/STAT
A2M alpha-2-macroglobulin 5.07 * 1.79 2.23
CSN2 casein beta 5.23 ** 21.54 1.48
CXCL9 chemokine (C-X-C motif) ligand 9 2.22 21.59 1.06
IRF1 interferon regulatory factor-1 1.90 22.94 1.00
MMP10 matrix metallopeptidase 10 1.09 21.12 2.50
NOS2A nitric oxide synthase 2A 1.26 1.21 8.01 **
PI3K/AKT
BCL2 B-cell CLL/lymphoma 2 3.54 21.54 1.86 **
CCND1 cyclin D1 1.54 29.09 *** 3.22 *
FN1 fibronectin 1 1.50 1.03 6.28 **
MMP7 matrix metallopeptidase 7 2.05 1.91 3.05 **
MYC v-MYC myelocytomatosis viral oncogene homolog 2.83 1.09 4.55
WISP2 WNT1 inducible signaling pathway protein 2 27.69 ** 1.50 24.55 ***
Jak/Src
BCL2 B-cell CLL/lymphoma 2 3.54 21.54 1.86 **
BCL2L1 BCL2-like 1; Bcl-X 24.92 25.00 ** 23.33
p53
GADD45A growth arrest and DNA-damage-inducible, alpha 5.22 * 21.15 1.96
IGFBP3 insulin-like growth factor binding protein 3 26.67 * 21.04 1.18 *
MDM2 Mdm2 p53 binding protein homolog (mouse) 6.83 * 21.82 2.89
Phospholipase C
EGR1 early growth response 1 22.70 22.50 * 1.09
FAS fas (TNF receptor superfamily, member 6) 22.38 1.15 22.63 *
FOS FBJ murine osteosarcoma viral oncogene homolog 22.78 * 1.56 21.59
JUNB jun B proto-oncogene 21.01 22.56 21.33
PTGS2 rostaglandin-endoperoxide synthase 2 1.26 1.21 8.01
TGF-b
CDKN1A cyclin-dependent kinase inhibitor 1A 1.12 * 4.01 * 1.10
CDKN2A cyclin-dependent kinase inhibitor 2A 1.89 1.35 24.17 **
CDKN2B cyclin-dependent kinase inhibitor 2B 21.19 2.72 22.27
CDKN2D cyclin-dependent kinase inhibitor 2D 1.31 24.55 ** 1.05
Retinoic Acid
CDX1 caudal type homeobox 1 1.31 2.05 1.09
CTSD cathepsin D 21.05 23.70 21.12
EN1 engrailed homeobox 1 21.10 22.22 1.00
RBP1 retinol binding protein 1, cellular 1.68 23.03 * 1.00
Androgen
CDK2 cyclin-dependent kinase 2 3.86 21.45 3.44 **
KLK2 kallikrein-related peptidase 2 6.83 *** 21.82 2.89
Signaling by HSV Glycoproteins
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(1000 particles per cell) or were mock-treated. Cells were harvested
every hour until 9 hr post treatment, lysed and assayed for
luciferase activity in triplicate. Figure 1(a) shows the fold-change in
luciferase activity of those HFFs inoculated with DgH in
comparison to mock-inoculated cells at the same time point.
Biological duplicates of the inoculations were performed with the
lysates used in triplicate reporter assays. At 1 hpi, there is an
average of 2.4 fold change in luciferase activity from the NF-kB
reporter, rising to 3.5 at 2 hpi and is maintained through to 3 hpi
whereby it drops to 1.8 at 4 hpi, which correlates with the half-life
of luciferase [28]. By 5 hpi, and until 9 hpi, luciferase activity
drops to baseline levels at, or near, 1-fold change. Error bars
represent the standard error across the six readings taken from
technical triplicates on biological duplicates.
As induction of the NF-kB reporter construct occurred within
one hour of inoculation with DgH virions and peaked at around
two-and-a-half hours post-inoculation, then the transcripts previ-
Gene Description DgB DgD DgH
TMEPA1 prostate transmembrane protein, androgen induced 1 3.69 1.41 23.13 ***
Hedgehog
BMP4 bone morphogenetic protein 4 22.22 * 22.38 21.67
HFFs were stimulated with 1000 particles/cell of DgB, DgD or DgH HSV-1 for six hours and a cDNA microarray corresponding to targets of 19 signalling pathways was
used to detect changes in cellular gene expression when compared to mock-infected. Infections and mock infections were carried out in duplicate. A number of
signalling pathways were shown to be stimulated by one or more of the entry-defective mutants. These data were used to independently verify changes in expression
using real-time PCR.
doi:10.1371/journal.pone.0009560.t001
Table 1. Cont.
Table 2. Independent confirmation of microarray data by real-time PCR.
Gene Description DgB DgD DgH
NF-KB
BIRC2 baculoviral IAP repeat-containing 2 3.66 * 1.20 2.92
BIRC3 baculoviral IAP repeat-containing 3 4.45 ** 1.27 3.71 **
CCL2 macrophage chemoattractant protein-1 2.09 21.51 3.16 **
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) 3.54 *** 1.13 2.61 *
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 2.35 *** 1.07 1.48 *
NFKBIB nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta 2.72 ** 1.16 1.40
PECAM1 platelet/endothelial cell adhesion molecule (CD31 antigen) 3.49 ** 1.22 4.44 **
REL v-REL reticuloendotheliosis viral oncogene homolog (C-REL) 2.05 21.25 2.63 *
JAK/STAT
A2M alpha-2-macroglobulin 3.54 ** 1.77 2.55 **
MMP10 matrix metallopeptidase 10 2.87 ** 1.52 2.62 ***
NOS2A nitric oxide synthase 2A 5.00 ** 21.09 4.41 *
PI3K/AKT
BCL2 B-cell CLL/lymphoma 2 2.86 * 22.33 * 2.13
MMP7 matrix metallopeptidase 7 3.67 * 21.03 2.04
MYC v-MYC myelocytomatosis viral oncogene homolog 4.53 *** 21.04 2.67 *
Jak/Src
BCL2 B-cell CLL/lymphoma 2 2.86 * 22.33 * 2.13
BCL2L1 BCL2-like 1; Bcl-X 2.56 ** 21.92 * 2.09 **
Androgen
CDK2 3.01** 1.18 3.08**
Note.
*p,0.05.
**p#0.01.
***p#0.001.
HFFs were stimulated with 1000 particles/cell of entry-defective HSV-1 and changes in cellular gene expression were detected by real-time PCR at 6 hours post-
inoculation. NF-kB responsive genes appear to be up-regulated by binding of either DgB or DgH virions to the cell. The increase in NF-kB-associated transcripts appears
specific as not all targets were differentially regulated. A similar pattern of gene expression is seen for Jak/Stat pathway targets in that DgD virions appear to be unable
to stimulate signalling whereas DgB and DgH binding can. MMP7 is only associated with the PI3 Kinase/Akt pathway and coupled with the up-regulation of BCL2,
CCND1 and MYC, it would appear that binding may be sufficient to also stimulate this pathway, although not by virions lacking in gD. The Jak/Src pathway only
contains two targets on the signalling specific microarray, one of which, BCL2, was associated with other pathways.
doi:10.1371/journal.pone.0009560.t002
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virions binding were examined for changes in transcript levels at
two-and-a-half hours after inoculation with DgH. Figure 1(b)
compares expression levels at two-and-a-half and six hours post-
inoculation. Transcripts for the NF-kB-responsive chemokine
CCL2 were up-regulated to a greater degree at two-and-a-half
hours than at six hours post-inoculation. Of the NF-kB-responsive
genes, REL transcription was induced to a higher level whereas
PECAM1 transcript abundance was reduced in comparison to six
hours. Although JAK/STAT-responsive targets were not differ-
entially expressed by two-and-a-half hours, the JAK/Src targets
BCL2 and BCL2L1 were up-regulated above the two-fold
arbitrary threshold to similar transcript levels that were seen at
six hours post-inoculation.
Interferogenic Capacity of Entry-Defective Virions
The initial microarray screen was uninformative with respect to
interferon signalling, but this was of interest because soluble gD
has been reported to induce IFN [29], while, in contrast, ISG
induction is reported to require virion entry but not de novo protein
synthesis
[30]. Primers were designed to Type I interferons,
a (IFNA1) and H (IFNB1), and the newly designated Type III
interferon l (IL29). Human fibroblasts do not produce interferon
gamma. Additionally, the cDNA preparation was used to identify
any change in the abundance of ISGs. Both DgB and DgH virions
were able to stimulate the up-regulation of IFN-a expression 2.81
fold and 2.34 fold, respectively, with a high degree of statistical
significance (p#0.05) (Table 4). HSV-1 particles lacking gD were
unable to do so, with a fold change of 21.11 and a p=0.15
(Table 4).
IFN-H transcript levels were up-regulated 2.22 fold by DgB
virions and 2.06 fold (p=0.01) by DgD virions, again with a high
degree of statistical significance. Inoculation with virus particles
lacking gH led to a 21.07 fold change (p=0.44) in IFN-H
expression when compared to mock-infected cultures. All three
entry-defective mutants were unable to modulate the expression of
IFN-l above the arbitrary two-fold threshold.
The glycosylation status of IFN-inducing viral glycoproteins is
a potential determinant of induction efficacy [22][31]. HSV-1 gD
has three potential N-glycosylation sites but lacks O-linked
glycosylation. DgH virions, that retain expression of gD, were
treated with the endoglycosidase, PNGase F, which removes N-
linked sugars. A long incubation was required as the denaturing
buffer was excluded from the reaction to avoid conformational
changes that might abrogate virion binding. As previously shown,
wild-type virions treated in a similar manner retained infectivity
(Figure S1) [22].
HFF were inoculated as above with DgH virions that had been
incubated for 18 hrs in the presence or absence of PNGase.
Glycosylated and deglycosylated DgH virions stimulated a 2.23
and 2.28 fold increase in IFN-a transcription, respectively. These
results suggest that glycosylation has no impact on the interfero-
genic properties of DgH virions, unlike the glycoproteins of MHV
and TGEV, which appear to stimulate Type I IFN through
Table 3. Comparison of microarray with real-time PCR data for differentially expressed genes.
Gene DgB DgD DgH
Microarray Real-Time Microarray Real-Time Microarray Real-Time
NF-KB
BIRC2 3.66 3.85 1.20 3.98 2.92 21.01
BIRC3 4.45 2.88 1.27 1.00 3.71 7.71
CCL2 2.09 2.32 21.51 1.34 3.16 2.13
NFKB1 3.54 2.98 1.13 21.92 2.61 3.09
NFKBIA 2.35 21.19 1.07 1.23 1.48 2.54
NFKBIB 2.72 - 1.16 - 1.40 -
PECAM1 3.49 4.60 1.22 1.00 4.44 3.09
REL 2.05 - 21.25 - 2.63 -
JAK/STAT
A2M 3.54 5.07 1.77 1.79 2.55 2.23
MMP10 2.87 1.09 1.52 21.12 2.62 2.50
NOS2A 5.00 1.26 21.09 1.21 4.41 8.01
PI3K/AKT
BCL2 2.86 1.86 22.33 21.54 2.13 1.86
MMP7 3.67 2.05 21.03 1.91 2.04 3.05
MYC 4.53 2.83 21.04 2.85 2.67 2.48
Jak/Src
BCL2 2.86 1.86 22.33 21.54 2.13 1.86
BCL2L1 2.56 1.42 21.92 25.00 2.09 21.18
Androgen
CDK2 3.01 3.86 1.18 21.45 3.08 3.44
There was a degree of correlation between the change in expression determined by microarray studies and those confirmed by real-time PCR, particularly for genes
under the control of NF-kB. Note: rel and nfkbib were not present on the original signalling-specific microarray, but were included in the real-time analysis, as they are
known to be up-regulated as part of the NF-kB feedback mechanism.
doi:10.1371/journal.pone.0009560.t003
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PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9560Figure 1. Kinetics of signalling activation. (A) An NF-kB luciferase construct was transfected into HFF, which were left to serum-starve for five days.
Cells were then mock-infected or inoculated with 1000 particles/cell of entry-defective DgH HSV-1 then lysed at the indicated times and assayed for
luciferase activity. Error bars are the +/2 standard error across triplicate luciferase assays for each biological duplicate. (B) NF-kB, JAK/STAT, JAK/Src and
PI3K/Akt-responsive genes that were previously shown to be differentially expressed at 6 hours post-inoculation with DgB and DgH virions were
examined for changes in expression at two-and-a-half hours after inoculation with 1000 particles/cell of DgH virions. The induction of JAK/STAT and PI3K/
Akt targets is not significantly up-regulated above the two-fold threshold by two-and-a-half hours post-inoculation. A number of NF-kB-associated
transcripts are significantly up-regulated, with ccl2 showing a far greater induction at two-and-a-half hours than six hours. Both JAK/Src targets, bcl2 and
bcl2l1 are induced to similar levels found at six hours post-inoculation. Error bars are the +/2 standard error across triplicate biological replicates.
doi:10.1371/journal.pone.0009560.g001
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through a different mechanism, possibly analogous to that used to
stimulate other signalling pathways.
Five interferon-stimulated genes were chosen to examine
whether they were differentially expressed by virion binding.
IFN-induced protein 54 (ISG54) transcripts are routinely used as
a marker of ISG induction. Binding by DgB, DgD or DgH virions
was insufficient to cause changes in the transcript abundance of
interferon regulatory factor-1, -3, -7, -9 or ISG54 (Table 4).
To ensure that these observations could not result from
a background of infection by competent virus, parallel cultures
were infected with wild type virus at an MOI of 0.01, a level of
infection some tenfold higher than would result from the ‘worst case’
scenario using preparations of entry defective virions (see Methods).
These cultures exhibited no induction of IFN or ISGs (Table 4).
Effects of DgH Virion Multiplicity on Stimulating
Signalling
All the experimental work described above was performed using
treatments with 1000 virus particles per cell, a condition that
would be unlikely to pertain in natural primary infections. To
establish whether much lower virion numbers would be effective,
HFFs were serum-starved for five days then mock-inoculated or
inoculated with 1, 10, 100 or 1000 particles per cell of DgH HSV-
1 for six hours. Infections were carried out in duplicate with mock-
inoculated controls that received an equivalent volume of PBS.
Total RNA was purified and reverse transcribed, with the cDNA
from each duplicate inoculation used in triplicate for real-time
PCR.
The NF-kB responsive genes NFKB1, REL and CCL2, in
addition to the JAK/STAT target NOS2A, were used as they had
previously been shown to be differentially expressed after
inoculation with 1000 particles/cell of DgH HSV-1. Recalling
that the more abundant a transcript the fewer number of cycles it
takes to cross a threshold set in the exponential phase of PCR
product accumulation (the CT value), Figure 2 plots the DCT value
on the y-axis, (i.e. the CT value for the gene of interest after
normalisation against the RPL13) against the multiplicity of
infection on the x-axis. As the multiplicity of DgH increases the CT
value decreases, indicating an increase in the abundance of
transcripts for all three NF-kB targets (Figure 2(a)). A logarithmic
regression analysis across three logs of multiplicity show a high
correlation between the four CT values for each transcript with
r
2.0.98. Similarly for the JAK/STAT responsive target NOS2A
there are almost two cycles of a difference between the level of
transcripts after infection with 1 particle/cell compared to
1000 particles/cell (Figure 2(b)). This larger response than those
for NF-kB responsive genes is indicative of the different level of
induction shown with previous real-time PCR analysis of these
transcripts (Table 2).
Arrows in Figure 2 indicate the CT value for each of the four
targets examined. Inoculation with 1 particle cell gave no
detectable increase in transcript abundance but an increase was
observed using 10 particles per cell and the dose response curves
strongly suggest that lower doses have an effect. Interpreting these
data in the context of infection is not straightforward as
particle:infectivity ratios for herpes simplex virus are, at best, 20
or more. On this basis a single infectious unit per cell is clearly
sufficient to increase transcript abundance, indicating that
signalling occurs at ‘physiological’ multiplicities of infection.
Discussion
Evidence from previous studies using soluble HSV-1 glycopro-
tein and UV-inactivated virus suggested that binding of HSV-1
virions to the cell surface might be sufficient to stimulate
intracellular signalling pathways. We undertook preliminary
microarray studies with entry-defective HSV-1 virions and
identified a number of pathways that were stimulated at early
time points during infection.
Microarray experiments are inevitably vulnerable to false
positives and negatives due to non-specific binding of labelled
cDNA probes, necessitating a more robust follow-up with highly
sensitive methods. Due to such confounders, these data were used
exclusively as a guide to select, for real-time PCR, the
transcriptional targets of intracellular signalling pathways stimu-
lated after inoculation with entry-defective HSV-1.
Gene targets associated with the NF-kB, JAK/STAT/Src, and
PI3K/Akt pathways were shown to be differentially expressed
after inoculation with glycoprotein-deficient virions, with the
majority of signalling events being associated with the presence of
gD on the envelope. Nineteen other signalling pathways present
on the preliminary microarray experiments, and confirmed by
real-time PCR, were not stimulated (data not shown). These
results are compatible with our model, shown in Fig. 3.
Real-time PCR confirmed that changes in transcription
associated with the NF-kB, JAK/STAT, JAK/Src and PI3K
pathways were modulated as a result of virion binding, all of which
required gD on the envelope surface To demonstrate that
signalling occurred at physiologically relevant multiplicities of
infection, HFFs were inoculated with either 1000, 100, 10 or 1
particles per cell of entry-defective HSV-1. Changes in gene
transcription occurred in a dose-dependent manner and were
detectable at 10 virus particles per cell. Given the particle:infec-
tivity ratios usually quoted for HSV1, we argue that this
corresponds to physiological conditions (i.e. less than one
infectious unit per cell), but it is impossible to know the
circumstances that pertain in vivo when a single cell becomes
infected. What seems almost certain is that an infected cell will
normally present an uninfected neighbouring cell with 10 or more
progeny particles.
HSV-1, as well as beta- and gammaherpesviruses, are capable
of stimulating the NF-kB pathway in a bi-phasic manner, with our
Table 4. Interferon response to HSV-1 virion binding.
Name Description DgB DgD DgH MOI 0.01
IFNA1 interferon, alpha 1 2.63 * 21.11 2.25 * 21.23
IFNB1 interferon, beta 1, fibroblast 3.01 * 2.15 * 21.07 21.18
IL29 interleukin 29 (interferon,
lambda 1)
1.51 21.33 21.69 1.11
ISG54 IFN-induced protein 54 1.20 1.57 21.54 21.45
IRF1 interferon regulatory factor 1 21.21 1.07 1.36 1.00
IRF3 interferon regulatory factor 3 1.14 21.10 1.05 1.08
IRF7 interferon regulatory factor 7 1.19 1.03 21.05 21.23
IRF9 interferon regulatory factor 9 21.23 1.03 1.44 21.33
Note.
*p,0.05.
Binding by DgB and DgH virions up-regulated the expression of IFN-a whereas
DgB and DgD virions were able to stimulate an increase in IFN-b. Infection with
wild-type HSV-1 at an MOI of 0.01 was insufficient to cause similar increases in
interferon expression. Interferon-stimulated genes were not up-regulated
above the two-fold threshold by binding of any of the entry-defective HSV-1
mutants. Wild-type infection at a low MOI was also insufficient to cause in
increase in ISG transcripts when compared to mock-infected cells.
doi:10.1371/journal.pone.0009560.t004
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PLoS ONE | www.plosone.org 8 March 2010 | Volume 5 | Issue 3 | e9560Figure 2. Effects of virion multiplicity on gene transcription. Low multiplicities of infection, which may represent physiological conditions,
were sufficient to trigger an intracellular signalling response. (A) As the number of inoculated DgH particles increases, the number of cycles taken to
reach the cycle threshold decreases for the NF-KB-responsive genes nfkbi, ccl2 and rel, indicating an increased abundance of transcript. (B) A similar
dose response is seen for the JAK/STAT target nos2a. Error bars are the +/2 standard error across triplicate biological replicates.
doi:10.1371/journal.pone.0009560.g002
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virions expressing gD [8] [32–33]. Suppression of NF-kB activity
is via negative feedback up-regulation of the inhibitor IkBa (nfkbia),
which was also stimulated by the binding of entry-defective HSV-1
virions. The triggering of early NF-kB transcriptional activity was
most likely through the coupling of gD on entry-defective virions
to the TNF superfamily receptor HvEM [1]. In doing so, not only
does the initial activation of this pathway allow for the subsequent
sequestration of the NF-kB p65 subunit to the ICP0 promoter, but
is crucial for immediate-early gene transcription and subsequent
HSV-1 replication [8].
Intracellular signalling induced by soluble gD can protect against
Fas-mediated apoptosis with inhibition of NF-kB signalling leading to
a loss of this protection [6]. Infection with UV-inactivated virions also
led to an increase in the expression of the anti-apoptotic protein c-
IAP2 (birc3), which we have demonstrated to be up-regulated after
inoculation with entry-defective virions containing gD. Additional
studies have supported the anti-apoptotic role for NF-kB during
HSV-1 infection yet there are conflicting data that demonstrate
possible pro-apoptotic activity [34][35]. This inconsistency may be
due to differing cell types used in those studies. Primary human
foreskin fibroblasts have been shown to be resistant to apoptosis after
infection with recombinant HSV-1 that is unable to express ICP4 or
ICP27 whereas infection with either virus has been shown to cause
apoptosis in transformed cell lines [36].
Aspects of the HSV-1 life cycle, such as stimulating the
progression of the cell cycle in the absence of serum, may be
sufficient to induce a stress response and trigger apoptosis. Both
bcl2 (Bcl-2) and bcl2l1 (Bcl-xl) belong to the Bcl-2 family of
apoptosis regulators that provide cellular protection from a range
of harmful stimuli such as cytokine deprivation, UV- and c-
irradiation [37]. Bcl-2 and Bcl-xl are found in the outer
mitochondrial membrane and are thought to suppress apoptosis
by blocking mitochondrial outer-membrane permeabilisation
through the sequestration of pro-apoptotic Bcl2 family members
[38]. Given the up-regulation of four anti-apoptotic genes, birc2,
birc3, bcl2 and bcl2l1, through the activation of multiple signalling
pathways by entry-defective HSV-1, this establishes a role for gD
binding in shifting the intracellular environment towards a more
anti- apoptotic stance.
Figure 3. Model for glycoprotein-receptor interactions in the induction of intracellular signalling pathways by HSV-1. Glycoprotein D
acts as the main signalling molecule on the surface of the HSV-1 envelope. gH interacts with avb3 integrins to potentially trigger the production of
IFN-b, which is known to involve IRF-3 and 7 [48]. Binding by gD to HvEM may lead to the activation of TRAF molecules, which in turn stimulate the
NF-kB signaling cascade. This pathway up-regulates a number of cellular genes in addition to augmenting early viral gene expression. NF-kB-
responsive genes, birc2 and birc3, have an anti-apoptotic role, but paradoxically, inflammatory mediators such as ccl2 are also up-regulated. gD-
induced signalling of the Jak/Stat and Jak/Src pathways also results in the differential expression of genes associated with anti-apoptosis and
inflammation. The up-regulation of c-Myc could lead to a corresponding increase in cdk2, which has a role in promoting DNA replication and gene
transcription during infection. It should be noted that most signalling cascades have been elucidated in non-fibroblast cells lines, so the role of
specific kinases may vary in HFFs.
doi:10.1371/journal.pone.0009560.g003
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immune response stimulated through HSV-1 binding. It may be
that there is a ‘‘cost’’ associated with altering the intracellular
environment, which leads to the differential expression of
cytokines, such as ccl2, that are under similar transcriptional
regulation as those host factors that are favourable for virus
replication.
Signalling by secreted Type I IFNs occurs through the Jak/Stat
pathway results in the expression of various ISGs; a response that
is also triggered by virus entry [39]. Nevertheless, productive
infection with HSV-1 can down-regulate the triggered ISG
response, allowing viral replication to continue unhindered [40].
Despite our evidence that gD binding by entry-defective virions
can induce IFN-a mRNA expression, independent of gD
glycosylation status, these data also fit with published observations
that binding by HSV-1 is insufficient to cause the up-regulation of
interferon-stimulated genes [30]. The up-regulation of IFN-b,
albeit it through a different mechanism, is suggestive of a previously
unidentified role for gH in eliciting a change in host gene
expression. An entry-defective HSV-1 mutant lacking gB that also
contains an RGE rather than the integrin binding RGD motif of
gH has been constructed and future studies may further elicit the
role of gH in interferon stimulation.
The methodology used here required the serum-starvation of
primary human fibroblasts for five days. In the absence of serum,
primary fibroblasts rapidly enter a quiescent state. As a DNA virus
that requires host nuclear factors to replicate its genome, it is
therefore not surprising that HSV-1 would stimulate cells from
a G0 state into one that would favour DNA replication and
possibly promote the transcription of viral genes.
Quiescent cells in vitro have very low levels expression of the
transcription factor c-Myc. Its up-regulation is rapidly induced
after mitogenic stimulation or the introduction of serum and
increased expression of c-Myc is consistent with the advancement
of cellular proliferation [41]. Control of myc transcription can be
influenced by a number of pathways, including PI3K/Akt
signalling, which was shown here to occur as a result of binding
by gD. A central role for c-Myc in promoting cell-cycle
progression is evident from the genes that it can up-regulate such
as eIF2 [42]. Progression of the cell cycle depends on the
additional activity of cyclin-dependent kinases. By interacting with
the promoters for genes encoding cyclins and cyclin-dependent
kinases, c-Myc can influence the advancement on the cell cycle
into the G1/S phase [43].
Cyclin-dependent kinase 2 (CDK2) is one such downstream
target of c-Myc activity, as well as the Androgen pathway,
highlighting the signalling cross-talk that may occur [44]. CDK2 is
involved in the progression of the cell cycle from G1 through to S
phase. Transient activation of CDK2 was shown to occur early in
HSV-2 infection at two hours post-infection, and is crucial in early
HSV-1 infection [45][46]. Kinase action by the cyclin A/CDK2
complex liberates the bound transcription factor E2F from Rb,
a transcription factor that has previously been shown to be active
during HSV-1 infection [47].
Epithelial cells at the initial site of HSV-1 infection in vivo are
likely to be in a resting state, necessitating the virus to evolve a pre-
entry signalling mechanism by which to stimulate the cell to
provide host factors that are necessary for viral replication. We
have demonstrated that signalling induced by HSV-1 glycopro-
teins, primarily gD, has the potential to: activate cellular
transcription factors that augment viral gene transcription,
differentially express a number of cellular genes so as to condition
the cell for optimal replication or, alternatively, signal transduction
may occur as a secondary effect to the appropriation of cellular
receptors to achieve viral entry.
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